RAC1 and ovarian cancer: R-ketorolac, but not S-ketorolac, inhibited Rac1-dependent cellular functions in ovarian cancer cell lines and primary cells including inhibition of growth factor-stimulated formation of filopodia, cell adhesion to fibronectin and type I collagen, development of invadopodia, and tumor cell migration [64].